Clinical Trial Update: Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update for AKL1 in obstructive airway diseases, including chronic obstructive pulmonary disease and asthma, sponsored by the Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Obstructive Lung Disease

Drugs mentioned

• AKL1

Snippet

Sponsor: University of East Anglia | Conditions: Obstructive Lung Disease, Chronic Obstructive Pulmonary Disease | Phase 2, Phase 3 | Status: UNKNOWN